Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Colorcon
Harvard Business School
Johnson and Johnson
McKinsey

Last Updated: February 7, 2023

CLINICAL TRIALS PROFILE FOR CARBACHOL


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Carbachol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00357864 ↗ Carbachol´s Headache Inducing Characteristics and Effects on the Cerebral Blood Flow Completed Danish Headache Center 2006-07-01 To investigate headache score and accompanying symptoms during and after infusion of carbachol.
NCT00564408 ↗ Carbachols Headache-inducing Effect and Changes in Cerebral Blood Flow in Migraine Patients Completed Danish Headache Center N/A 2007-08-01 The purpose of this study is to test if carbachol infusion induces headache in migraine subjects as well as intra- and extra-cerebral vasodilatation.
NCT00861211 ↗ Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects Completed Icagen Phase 2 2008-10-01 The purpose of the study is to determine whether senicapoc can decrease changes in FEV1 following allergen challenge in atopic allergic subjects.
NCT02807415 ↗ ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor Completed Heidelberg University 2016-06-01 The academic investigator - initiated trial will evaluate in a postapproval setting whether, and if yes, to what extent and variability, the treatment with lumacaftor in combination with ivacaftor reverses the p.Phe508del CFTR - mediated basic defect in p.Phe508del homozygous subjects with cystic fibrosis under real life conditions.
NCT02807415 ↗ ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor Completed University of Giessen 2016-06-01 The academic investigator - initiated trial will evaluate in a postapproval setting whether, and if yes, to what extent and variability, the treatment with lumacaftor in combination with ivacaftor reverses the p.Phe508del CFTR - mediated basic defect in p.Phe508del homozygous subjects with cystic fibrosis under real life conditions.
NCT02807415 ↗ ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor Completed Hannover Medical School 2016-06-01 The academic investigator - initiated trial will evaluate in a postapproval setting whether, and if yes, to what extent and variability, the treatment with lumacaftor in combination with ivacaftor reverses the p.Phe508del CFTR - mediated basic defect in p.Phe508del homozygous subjects with cystic fibrosis under real life conditions.
NCT04774237 ↗ Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia Completed Visus Therapeutics Phase 2 2021-03-24 Safety and Efficacy Study of BRIMOCHOL™ vs. BRIMOCHOL™ F vs. Carbachol Monotherapy Topical Ophthalmic Solutions in Subjects with Emmetropic Phakic and Pseudophakic Presbyopia
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Carbachol

Condition Name

Condition Name for Carbachol
Intervention Trials
Presbyopia 3
Headache 2
Atopic Asthma 1
Cystic Fibrosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Carbachol
Intervention Trials
Presbyopia 3
Headache 2
Cystic Fibrosis 1
Asthma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Carbachol

Trials by Country

Trials by Country for Carbachol
Location Trials
Denmark 2
United States 2
United Kingdom 1
Germany 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Carbachol
Location Trials
Tennessee 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Carbachol

Clinical Trial Phase

Clinical Trial Phase for Carbachol
Clinical Trial Phase Trials
Phase 3 2
Phase 2 2
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Carbachol
Clinical Trial Phase Trials
Completed 5
Not yet recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Carbachol

Sponsor Name

Sponsor Name for Carbachol
Sponsor Trials
Visus Therapeutics 3
Danish Headache Center 2
Icagen 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Carbachol
Sponsor Trials
Other 8
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Colorcon
Baxter
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.